At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRFX PainReform
Post-Mkt 12-05 19:27:19 EST
0.9606
-0.0594
-5.82%
盘后0.9300
-0.0306-3.19%
19:01 EST
High1.21Low0.8658Vol1.50M
Open1.06D1 Closing1.02Amplitude33.75%
Mkt Cap3.76MTradable Cap3.59MTotal Shares3.92M
T/O1.67MT/O Rate40.04%Tradable Shares3.74M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

BRIEF-Painreform Commences Development For Ocuring™-K Phase II Trial
Reuters  ·  12-02
BRIEF-Painreform Commences Development For Ocuring™-K Phase II Trial
PainReform Advances Drop-Less OcuRing-K Therapy Toward Phase II Trial
Reuters  ·  12-02
PainReform Advances Drop-Less OcuRing-K Therapy Toward Phase II Trial
PainReform Commences Development for Ocuring™-K Phase Ii Trial, Layerbio’s Drop-Less Sustained-Release Ocular Therapy
THOMSON REUTERS  ·  12-02
PainReform Commences Development for Ocuring™-K Phase Ii Trial, Layerbio’s Drop-Less Sustained-Release Ocular Therapy
PainReform Ltd. Announces December 2025 Shareholders Meeting with Key Proposals
TIPRANKS  ·  11-26
PainReform Ltd. Announces December 2025 Shareholders Meeting with Key Proposals
PainReform Ltd. Announces Date for Upcoming Annual General Meeting of Shareholders
Reuters  ·  11-26
PainReform Ltd. Announces Date for Upcoming Annual General Meeting of Shareholders
PainReform’s DeepSolar advances development of AI-driven reporting engine
TIPRANKS  ·  11-12
PainReform’s DeepSolar advances development of AI-driven reporting engine
DeepSolar Advances AI-Driven Reporting Engine for Solar Asset Analysis
Reuters  ·  11-12
DeepSolar Advances AI-Driven Reporting Engine for Solar Asset Analysis
PainReform’s DeepSolar Advances with NVIDIA Connect and Pilot Projects
TIPRANKS  ·  11-05
PainReform’s DeepSolar Advances with NVIDIA Connect and Pilot Projects
BRIEF-PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects
Reuters  ·  11-05
BRIEF-PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects
PainReform’s Deepsolar, Developing “Deepsolar Predict” Within the Nvidia Connect Program, Featured in the Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects
THOMSON REUTERS  ·  11-05
PainReform’s Deepsolar, Developing “Deepsolar Predict” Within the Nvidia Connect Program, Featured in the Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects
BRIEF-Painreform Provides Business Update For The Six Months Ended June 30, 2025
Reuters  ·  10-01
BRIEF-Painreform Provides Business Update For The Six Months Ended June 30, 2025
PainReform Announces H1 2025 Financial Results and Board Change
TIPRANKS  ·  10-01
PainReform Announces H1 2025 Financial Results and Board Change
PainReform Ltd. Reports Reduced Net Loss and Maintains Positive Working Capital for First Half of 2025
Reuters  ·  10-01
PainReform Ltd. Reports Reduced Net Loss and Maintains Positive Working Capital for First Half of 2025
Press Release: PainReform Provides Business Update for the Six Months Ended June 30, 2025
Dow Jones  ·  10-01
Press Release: PainReform Provides Business Update for the Six Months Ended June 30, 2025
Top Midday Gainers
MT Newswires Live  ·  08-20
Top Midday Gainers
DeepSolar, a Subsidiary of PainReform Ltd., Joins NVIDIA Connect Program to Enhance AI-Driven Solar Forecasting
Reuters  ·  08-19
DeepSolar, a Subsidiary of PainReform Ltd., Joins NVIDIA Connect Program to Enhance AI-Driven Solar Forecasting
PainReform/Deepsolar Accepted Into Nvidia Connect Program
THOMSON REUTERS  ·  08-19
PainReform/Deepsolar Accepted Into Nvidia Connect Program
PainReform Ltd. Announces New Clinical Trial for Breakthrough OcuRing™-K Technology Targeting Post-Cataract Surgery Pain Management
Reuters  ·  08-14
PainReform Ltd. Announces New Clinical Trial for Breakthrough OcuRing™-K Technology Targeting Post-Cataract Surgery Pain Management
PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System
GlobeNewswire  ·  08-13
PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System
PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio
GlobeNewswire  ·  07-10
PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio

Introduction

Company Name.
PainReform
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
Issue price:
--